Physician profile
Anne Kinuyo Jinbo
NPI 1689862856
$7,548.72
in general payments reported to CMS, 2019-2025
7 companies · $6,061 in 2025
The $6,061 reported for 2025 was more than what 99% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.30 · 2023: $904 · 2024: $492 · 2025: $6,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,331 · Food and Beverage: $1,927 · Travel and Lodging: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,331.35 |
| Food and Beverage | $1,927.29 |
| Travel and Lodging | $197.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $6,069.75 | 2024-2025 | |
| Kci USA, INC. | $885.72 | 2023 | Promogran Prisma, Activ.A.C., V.A.C. Dermatac |
| Solventum Corporation | $291.95 | 2024-2025 | Activ.A.C., V.A.C. Dermatac, Promogran Prisma |
| Convatec INC. | $177.63 | 2025 | |
| Medline Industries Lp | $75.61 | 2022 | |
| Hollister Incorporated | $34.57 | 2022-2023 | Premier, New Image |
| Hydrofera LLC | $13.49 | 2024 | Cutimed Sorbion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Jinbo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.